Ghrelin - A Possible Opportunity to Improve Appetite

Göteborg University30 enrolled

Overview

The study is designed to evaluate whether ghrelin treatment can improve appetite in weight losing cancer patients.

Randomized study with follow up evaluations each month until preterminal state. Cancer patients will be randomised to either high dose or low dose of active treatment given as daily injection.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Cancer

Interventions

GhrelinDRUG

High dose of ghrelin given as subcutaneous injection once a day for the duration of 8 weeks.

GhrelinDRUG

Low dose of ghrelin given as subcutaneous injection once a day for the duration of 8 weeks.

Eligibility

Sex: ALLMin age: 40 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Weight loss Exclusion Criteria: * Diabetes

Locations (1)

Department of surgery, Sahlgrenska University Hospital

Gothenburg, Sweden

Outcomes

Primary Outcomes

Food intake

Time frame: June 2008

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.